SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067700
Filing Date
2014-11-13
Accepted
2014-11-13 16:00:49
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392687_10q.htm 10-Q 353731
2 EXHIBIT 4.1 v392687_ex4-1.htm EX-4.1 124709
3 EXHIBIT 31.1 v392687_ex31-1.htm EX-31.1 8175
4 EXHIBIT 31.2 v392687_ex31-2.htm EX-31.2 8425
5 EXHIBIT 32.1 v392687_ex32-1.htm EX-32.1 5536
  Complete submission text file 0001144204-14-067700.txt   4437079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cpxx-20140930.xml EX-101.INS 679098
7 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20140930.xsd EX-101.SCH 37548
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20140930_cal.xml EX-101.CAL 41596
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20140930_def.xml EX-101.DEF 193725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20140930_lab.xml EX-101.LAB 269762
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20140930_pre.xml EX-101.PRE 238628
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 141218337
SIC: 2834 Pharmaceutical Preparations